AstraZeneca’s Enhertu wins keenly-anticipated U.S. breast cancer nod
AstraZeneca (AZN.L) and Daiichi Sankyo (4568.T) on Friday secured U.S. approval that broadens the use of their therapy Enhertu, for patients with breast cancer, and paves the way...
Korean Company GenKOre Offering Genetic Base-Editing Tech
Adenine base editors were successfully created by GenKOre, a biotech startup in South Korea, using its unique hypercompact gene-editing method.
The hypercompact ABEs created by...
Beovu, Made By Novartis, Earns A Recommendation From NICE
Following NICE's recommendation of a novel therapy alternative for diabetic macular oedema (DMO), thousands of patients could receive transformative care. In the final form...
Lilly, AZ, AbbVie, And J&J Could Be Hurt By Medicare Bill
Could the Senate adopt a "watershed" bill allowing drug price discussions after years of government inaction regarding medication prices in the U.S.? Analysts are busy...
September May See Advent of Revised COVID-19 Booster Shots
According to the US Department of Health and Human Services, booster shots from Moderna and Pfizer that have been upgraded to target Omicron coronavirus...
First Patient Adopting TAC-001 Has Been Announced By Tallac
In a phase 1/2 clinical trial for patients with locally advanced or metastatic solid tumours, Tallac Therapeutics has reported that the first patient has...
Arcutis Receives FDA Nod For Their Zoryve Psoriasis Cream
Pfizer previously held out hope that Eucrisa would become the trendiest topical treatment for inflammatory skin conditions. However, the ointment never took off because...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...